Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prurigo Nodularis (PN)”

19 trials

Showing 19 of 19 results

Testing effectiveness (Phase 2)Study completedNCT05061693
What this trial is testing

Evaluate the Efficacy and Safety of INCB054707 in Participants With Prurigo Nodularis

Who this might be right for
Prurigo Nodularis
Incyte Corporation 146
Large-scale testing (Phase 3)Study completedNCT04501679
What this trial is testing

Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)

Who this might be right for
Prurigo Nodularis
Galderma R&D 274
Early research (Phase 1)Study completedNCT05405985
What this trial is testing

Study to Access the Relative Bioavailability of Subcutaneous Dose of Nemolizumab When Administered Via Auto-Injector Versus Dual-Chamber Syringe

Who this might be right for
Healthy Volunteers
Galderma R&D 192
Testing effectiveness (Phase 2)Study completedNCT03181503
What this trial is testing

Safety and Efficacy of Nemolizumab in PN

Who this might be right for
Prurigo Nodularis
Galderma R&D 70
Large-scale testing (Phase 3)Active Not RecruitingNCT06516965
What this trial is testing

Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2)

Who this might be right for
Prurigo Nodularis
Incyte Corporation 346
Not applicableLooking for participantsNCT07276425
What this trial is testing

Early and Long-Term Efficacy and Immune Changes With Dupilumab in Prurigo Nodularis

Who this might be right for
Prurigo Nodularis (PN)
UMC Utrecht 40
Large-scale testing (Phase 3)Study completedNCT05755438
What this trial is testing

Evaluate the Safety and Efficacy of Ruxolitinib Cream in Participants With Prurigo Nodularis (PN)

Who this might be right for
Prurigo
Incyte Corporation 204
Large-scale testing (Phase 3)Active Not RecruitingNCT04204616
What this trial is testing

A Long-term Study of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)

Who this might be right for
Prurigo Nodularis
Galderma R&D 500
Early research (Phase 1)Study completedNCT06213831
What this trial is testing

Evaluate the Safety and Tolerability of Maximal Use Ruxolitinib Cream

Who this might be right for
Prurigo Nodularis
Incyte Corporation 23
Large-scale testing (Phase 3)Study completedNCT04501666
What this trial is testing

Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)

Who this might be right for
Prurigo Nodularis
Galderma R&D 286
Large-scale testing (Phase 3)Active Not RecruitingNCT06516952
What this trial is testing

Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN1)

Who this might be right for
Prurigo Nodularis
Incyte Corporation 349
Testing effectiveness (Phase 2)Looking for participantsNCT07236099
What this trial is testing

Study of the Efficacy and Safety of ICP-332 in Participants With Prurigo Nodularis

Who this might be right for
Prurigo Nodularis (PN)
Beijing InnoCare Pharma Tech Co., Ltd. 135
Testing effectiveness (Phase 2)Study completedNCT00869089
What this trial is testing

Safety and Efficacy of CC-10004 for Prurigo Nodularis

Who this might be right for
Prurigo Nodularis
University Hospitals Cleveland Medical Center 5
Large-scale testing (Phase 3)Study completedNCT05764161
What this trial is testing

Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Prurigo Nodularis (PN)

Who this might be right for
Prurigo Nodularis
Incyte Corporation 190
Testing effectiveness (Phase 2)Active Not RecruitingNCT06366750
What this trial is testing

Barzolvolimab in Patients With Prurigo Nodularis

Who this might be right for
Prurigo Nodularis
Celldex Therapeutics 140
Large-scale testing (Phase 3)Study completedNCT03497975
What this trial is testing

PRISM Study-Pruritus Relief Through Itch Scratch Modulation

Who this might be right for
Prurigo Nodularis
Trevi Therapeutics 353
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07620561
What this trial is testing

Efficacy and Speed of Response of Lebrikizumab in High-Burden Prurigo Nodularis Patients

Who this might be right for
Prurigo Nodularis (PN)
University of Maryland, Baltimore 15
Testing effectiveness (Phase 2)Study completedNCT02196324
What this trial is testing

Placebo-Controlled Study of the Neurokinin-1 (NK1) Receptor Antagonist Serlopitant Prurigo Nodularis (PN)

Who this might be right for
Prurigo Nodularis
Vyne Therapeutics Inc. 128
Large-scale testing (Phase 3)Study completedNCT04183335
What this trial is testing

Study of Dupilumab for the Treatment of Patients With Prurigo Nodularis, Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable (LIBERTY-PN PRIME)

Who this might be right for
Neurodermatitis
Sanofi 151

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation